Form D · Biotechnology

FORMA THERAPEUTICS INC

Cambridge, MA · CIK 0001430390

Offering snapshot reported Dec 16, 2009 · SEC filing

Reported sold
$3M
Offering amount: $3M
Investors reported
6
Form D · investor count
Minimum accepted
$3M
Reported outside-investor minimum
First sale
Dec 10, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.7M$25.5MDec 1, 2009: $25,454,311.00Dec 1, 2009Dec 16, 2009: $3,000,000.00Dec 16, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$25,454,311 → $3,000,000
  • Minimum accepted$100,000 → $3,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 16, 2009Amendment$3,000,000-$22,454,311vs Dec 1, 20096SEC filing
Dec 1, 2009Initial$25,454,311No comparison6SEC filing
Mar 18, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-116165

Source: Form D, filed Dec 16, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven Tregay, Ph.D. Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
790 Memorial Drive Suite 2 B
Cambridge, MA, 02139